Sheinerman, Kira S.
Toledo, Jon B.
Tsivinsky, Vladimir G.
Irwin, David
Grossman, Murray
Weintraub, Daniel
Hurtig, Howard I.
Chen-Plotkin, Alice
Wolk, David A.
McCluskey, Leo F.
Elman, Lauren B.
Trojanowski, John Q.
Umansky, Samuil R.
Funding for this research was provided by:
National Institute on Aging (2R44AG044860-02, P30-AG10124, PO1-AG17586)
National Institute of Neurological Disorders and Stroke (P50-NS053488)
Article History
Received: 31 May 2017
Accepted: 19 October 2017
First Online: 9 November 2017
Ethics approval and consent to participate
: Patient recruitment and clinical data and blood collection were performed at the Alzheimer’s Disease Center, the Parkinson’s Disease and Movement Disorders Center, the Frontotemporal Degeneration Center, and the Amyotrophic Lateral Sclerosis Clinic according to protocols approved by the institutional review board at the University of Pennsylvania. Written informed consent was obtained from all study participants and/or their authorized representatives.
: Not applicable.
: KSS, VGT, and SRU are employees and shareholders of DiamiR. JBT, DI, MG, DW, HAH, ACP, DAW, LFM, LBE, and JQT declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.